-
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages
Источник: Buzz FX / 03 мар 2025 04:12:13 America/Chicago
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Rating of "Moderate Buy" by Brokerages Written by MarketBeat March 3, 2025 Share Link copied to clipboard. Esperion Therapeutics, Inc. ( NASDAQ:ESPR - Get Free Report ) has received a
Read more...